Bacterial blood infection, computer illustration. Researchers compared outcomes of continuous vs intermittent meropenem among critically ill patients with sepsis. Clinical outcomes among critically ...

Purpose: The stability of meropenem in i.v. solutions stored in polyvinyl chloride (PVC) bags and an elastomeric infusion device at concentrations commonly used in home care was studied. Methods: ...

Learn everything you need to know about Meropenem-pronunciation, uses, dosage guidelines, indications, and when to take or avoid it. Get up-to-date information on side effects, precautions, warnings, ...

Carbapenem-resistant Enterobacterales and multidrug-resistant Pseudomonas aeruginosa are a global threat to antimicrobial resistance and may be causative pathogens in cUTI. Cefepime-taniborbactam ...

The phase 3 CERTAIN-1 study compared the efficacy and safety of cefepime-taniborbactam to meropenem in 661 adults with cUTI. Positive results were announced from a phase 3 study evaluating ...

The content of this evidence review was up-to-date in November 2019. See summaries of product characteristics (SPCs), British national formulary (BNF), or the Medicines and Healthcare products ...

LAKE FOREST, Ill., June 22 /PRNewswire-FirstCall/ -- Hospira, Inc. (NYSE: HSP), the world leader in generic injectable pharmaceuticals, today announced it has ...

Discover comprehensive details about Meropenem and Vaborbactam, including its pronunciation, uses, dosage instructions, indications, and guidelines on how and when to take it or avoid it. The updated ...

Tango I was a randomised, double-blind, double-dummy trial that compared meropenem with vaborbactam (2 g/2 g IV [intravenous] over 3 hours, every 8 hours) with piperacillin with tazobactam (4 g/0.5 g ...

Meropenem 0.5-g a and 1-g b vials were used to prepare 4-mg/mL solutions. Each 0.5-g vial was reconstituted with 10 mL of sterile water for injection (SWFI) and each 1-g vial with 20 mL of SWFI to ...